The HemoScreen instrument is a point-of-care five-part differential complete blood count analyzer that is used for rapid testing from a drop of blood.

The company's CircleDNA and ACT Genomics businesses are on track to achieve business-unit breakeven in the second half of 2024, it said.

The company, based outside of Grenoble in the French Alps, together with its partners has received €5 million to pursue the project.

Called the Coalition for Effective Diagnostics, the organization has called on lawmakers to pass legislation revamping diagnostics regulation, including oversight of LDTs.

While Congress has protected labs from PAMA cuts via a series of one-year delays, this has locked lab prices at 2016 levels, ...

Last week, readers were most interested in a story about the development of an AI-based method to predict COPD flare-ups before symptoms appear.

According to the DOJ, Osman Syed submitted more than $79 million in fraudulent claims to Medicare and Texas Medicaid for RPP testing.

The company said that it is pairing its diagnostics and life sciences businesses to support growth and focus on shared end markets and customers.

The company said that gains in its Agilent CrossLab Group offset losses across its other two divisions as the company undertakes restructuring to grow as the market improves.

Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous ...

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

The UK-based firm is developing its initial panel tests for Gram-negative bacteria with tests for Gram-positive bacteria and ...